查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1881357

全球乳房X光攝影系統市場：依產品類型、模式、最終用戶和地區劃分 - 市場規模、行業趨勢、機會分析和預測（2025-2033）

Global Mammography Systems Market: By Product Type, Modality, End User, and Region - Industry Dynamics, Market Size, Opportunity and Forecast for 2025-2033
出版日期: | 出版商: Astute Analytica | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

近年來，乳房X光攝影系統市場經歷了強勁成長，反映出全球對乳癌早期檢測和改進診斷技術的日益關注。 2024年，該市場價值約為29.832億美元，顯示全球對乳房X光攝影系統的需求強勁。預計這一成長趨勢將在未來十年持續，到2033年達到57.1951億美元。 2025年至2033年的複合年增長率為7.5%，凸顯了該產業的擴張和發展趨勢。

推動這一強勁市場成長的關鍵因素有很多。其中一個主要推動因素是全球乳癌發生率的上升。由於乳癌仍然是女性最常見和最致命的癌症之一，因此對早期檢測的日益重視正在推動對高效乳房X光攝影系統的需求。早期篩檢和診斷對於改善患者預後至關重要，因此乳房X光檢查已成為全球癌症治療過程中不可或缺的工具。

市場趨勢

乳房X光系統市場競爭激烈，主要全球企業包括Hologic、GE醫療、西門子醫療和富士膠片控股等。數位成像、3D乳房X光檢查（斷層合成）和人工智慧輔助診斷系統等領域的持續技術創新極大地推動了這種競爭格局。

持續的技術創新和市場活躍的一個顯著例子是，全球醫療技術領導者西門子醫療於2025年11月在泰國推出該系統，進一步鞏固了其致力於改善乳腺癌早期檢測的承諾。該系統代表了成像技術的重大進步，提高了診斷準確性和患者舒適度。

同時，慈善捐款也為乳房X光技術的進步做出了貢獻。2025年10月，拿騷大學醫學中心 (NUMC) 收到一筆100萬美元的匿名捐款，用於購買一台新的3D乳房X光機和骨密度儀。這筆資金的注入使NUMC能夠加強其診斷基礎設施。

為了進一步展現市場的活力，2025年7月，印度醫療技術領域的先驅企業BPL醫療技術公司宣布與知名的放射學和癌症治療解決方案提供商Panacea醫療技術公司建立戰略合作夥伴關係。此次合作旨在透過Panacea在印度各地廣泛的診斷中心、婦科醫院和政府醫療機構網絡，提供先進的乳房X光解決方案。

核心成長驅動因子

乳房X光系統市場正日益受到超越傳統2D基本設備的先進技術的驅動。數位乳房斷層合成（DBT），也稱為3D乳房X光攝影，已成為已開發國家公認的標準診療技術。 DBT 的廣泛應用主要歸功於其優於傳統二維乳房X光攝影的臨床表現。臨床研究表明，DBT 在檢測浸潤性癌症方面更為有效，能夠實現早期診斷並改善患者預後。

新機遇

將乳房X光攝影影像用於機會性心血管疾病篩檢的創新應用正在成為乳房X光攝影系統市場的一個重要新機會。傳統上，乳房X光攝影幾乎完全專注於乳癌的檢測。然而，人工智慧 (AI) 的最新進展正在開闢新的途徑，利用現有的乳房X光攝影影像來評估其他重大健康問題的風險因素。具體而言，AI 演算法現在可以分析乳房X光照片上的乳房動脈鈣化 (BAC)。 BAC 是公認的與心血管疾病風險增加相關的標記。這項功能將常規乳房X光攝影轉變為雙用途診斷工具，無需額外檢查即可提供有關患者心臟健康的寶貴資訊。

優化障礙

儘管乳房X光檢查作為早期乳癌檢測的重要工具日益重要，但世界許多地區對乳房X光檢查的認知仍然不足。這種認知差距嚴重阻礙了乳房X光檢查系統的普及和廣泛應用，尤其是在發展中和欠發達地區。在這些地區，許多人並不了解定期乳癌篩檢的好處，或對篩檢程序有誤解，這限制了需求並減緩了市場擴張。如何向大眾普及乳房X光檢查的重要性仍然是更廣泛地推廣和利用乳房X光檢查的一大障礙。

目錄

第一章：研究架構

  • 研究目標
  • 產品概述
  • 市場區隔

第二章：研究方法

  • 質性研究
    • 一手和二手資料來源
  • 量化研究
    • 一手和二手資料來源
  • 依地區劃分的原始調查受訪者
  • 研究假設
  • 市場規模估算
  • 資料三角驗證

第三章：摘要整理：全球乳房X光攝影系統市場

第四章：全球乳房X光攝影系統市場概述

  • 產業價值鏈分析
    • 原料供應商
    • 製造商
    • 經銷商
    • 終端用戶
  • 行業展望
    • 乳房X光系統市場概述
    • 乳房X光檢查人口統計分析
  • 波特五力分析
    • 供應商議價能力
    • 買方議價能力
    • 替代品威脅
    • 新進入者威脅
    • 競爭強度
  • 市場動態與趨勢
    • 成長推動因素
    • 阻礙因素
    • 挑戰
    • 主要趨勢
  • 新冠疫情對市場成長的影響評估趨勢
  • 市場成長與展望
    • 市場收入估計與預測（2020-2033）
    • 價格趨勢分析
  • 競爭格局概覽
    • 市場集中度
    • 公司市佔率分析（價值，2024）
    • 競爭格局圖
    • 促銷行銷策略與獨特賣點 (USP)

第五章：全球乳房X光攝影系統市場依產品類型分析

  • 主要發現
  • 市場規模及預測（2020-2033）
    • 模擬乳房X光攝影系統
    • 數位乳房X光攝影系統

第六章：全球乳房X光攝影系統市場分析模式

  • 主要發現
  • 市場規模及預測，2020-2033 年
    • 便攜式乳房X光攝影系統
    • 非便攜式乳房X光攝影系統

第七章：全球乳房X光攝影系統市場依最終用戶劃分的分析

  • 主要見解
  • 市場規模及預測，2020-2033 年
    • 住院機構
    • 門診手術中心

第八章：全球乳房X光攝影系統市場依地區劃分的分析

  • 主要見解
  • 市場規模及預測，2020-2033 年
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲

第九章：北美乳房X光攝影系統市場分析

第十章：歐洲乳房X光攝影系統市場分析

第十一章：亞太地區乳房X光攝影系統市場分析

第十二章：中東與非洲乳房X光攝影系統市場分析

第十三章：南美洲乳房X光攝影系統市場分析

第十四章：公司簡介

  • Allengers Medical Systems Limited
  • 富士軟片控股株式會社
  • 通用電氣公司
  • Hologic Incorporated
  • 柯尼卡美樂達株式會社
  • 皇家飛利浦公司（飛利浦醫療保健）
  • Metaltronica SPA
  • Planmeca OY
  • 西門子股份公司
  • 東芝公司
  • 其他主要參與者
簡介目錄
Product Code: AA0622265

The mammography systems market has experienced robust growth in recent years, reflecting a growing global emphasis on early breast cancer detection and improved diagnostic technologies. In 2024, the market was valued at approximately US$ 2,983.2 million, underscoring the significant demand for mammography systems worldwide. This upward trajectory is expected to continue over the coming decade, with projections estimating the market will reach an impressive value of US$ 5,719.51 million by 2033. The compound annual growth rate (CAGR) for the period 2025-2033 is 7.5%, highlighting the expansion and evolving dynamics of the industry.

Several key factors are driving this strong market growth. One of the primary contributors is the rising prevalence of breast cancer globally. As breast cancer remains one of the most common and deadly cancers among women, there is an increasing emphasis on early detection, which fuels the demand for effective mammography systems. Early screening and diagnosis are critical for improving patient outcomes, making mammography an indispensable tool in cancer care pathways around the world.

Noteworthy Market Developments

The mammography systems market is marked by intense competition among several key global players, including Hologic, GE HealthCare, Siemens Healthineers, and Fujifilm Holdings. This competitive environment is largely fueled by continuous technological innovation, especially in areas such as digital imaging, 3D mammography (tomosynthesis), and AI-assisted diagnostic systems.

A notable example of ongoing innovation and market activity occurred in November 2025 when Siemens Healthineers, a global leader in medical technology, reinforced its dedication to improving early breast cancer detection by launching the MAMMOMAT B.brilliant in Thailand. This next-generation 3D mammography system represents a significant advancement in imaging technology, offering enhanced diagnostic accuracy and patient comfort.

In parallel, philanthropic support has also played a role in advancing mammography capabilities. In October 2025, Nassau University Medical Center (NUMC) received an anonymous donation of $1 million, which was allocated toward acquiring new 3D mammography and bone density scanning systems. This infusion of funds enables NUMC to upgrade its diagnostic infrastructure.

Further illustrating the dynamic nature of the market, July 2025 saw BPL Medical Technologies, a pioneer in the Indian medical technology sector, announce a strategic alliance with Panacea Medical Technologies, a well-established name in radiology and cancer care solutions. This partnership aims to deliver advanced mammography solutions through Panacea's extensive network of diagnostic centers, women's health hospitals, and government health institutions across India.

Core Growth Drivers

The mammography systems market is increasingly being driven by advanced technologies that go beyond the traditional basic 2D units. Among these, Digital Breast Tomosynthesis (DBT), also known as 3D mammography, has emerged as the undisputed standard of care in developed countries. The widespread adoption of DBT is largely attributed to its superior clinical performance compared to conventional 2D mammography. Clinical studies have demonstrated that DBT is more effective at detecting invasive cancers, which leads to earlier diagnosis and improved patient outcomes.

Emerging Opportunity Trends

A significant and emerging opportunity within the mammography systems market lies in the innovative use of mammograms for opportunistic screening of cardiovascular disease. Traditionally, mammography has been focused almost exclusively on the detection of breast cancer. However, recent advancements in artificial intelligence (AI) have opened new avenues for leveraging existing mammogram images to assess risk factors for other serious health conditions. Specifically, AI algorithms can now analyze breast arterial calcification (BAC), which appears on mammograms and is a well-established marker associated with increased risk of cardiovascular disease. This capability transforms routine mammography screenings into a dual-purpose diagnostic tool, offering valuable insights into a patient's heart health without any additional procedures.

Barriers to Optimization

Despite the increasing prominence of mammography as a crucial tool for the early detection of breast cancer, there remains a persistent lack of knowledge about mammography frameworks in many parts of the world. This gap in awareness significantly hinders the adoption and growth of mammography systems, particularly in developing and underdeveloped regions. Many individuals in these areas are either unaware of the benefits of regular breast cancer screening or hold misconceptions about the procedure, which limits demand and slows market expansion. The challenge of educating populations about the importance of mammography remains a critical obstacle to broader acceptance and utilization.

Detailed Market Segmentation

In terms of product type, analogue mammography systems hold a significant market share, accounting for over 66.20 percent. As a result of analogue technology being widely available and supported by established infrastructure, it has been the gold standard for screening breast cancer for decades. There are still many healthcare facilities that use analogue mammography systems, especially in regions where budget constraints or technological limitations exist.

By End User, Hospitals serve as the financial backbone of the mammography systems market, commanding a dominant market share of approximately 68.90%. Their prominence stems from their role as comprehensive healthcare providers, offering a full spectrum of services from initial diagnosis to treatment within inpatient settings. This all-encompassing approach allows hospitals to generate the highest revenue in the mammography market, as patients often rely on these facilities for both preventive screenings and subsequent medical care.

By Modality, Portable mammography systems have emerged as a transformative force within the mammography systems market, currently commanding a significant market share of over 53.80%. Their rapid growth and widespread adoption are reshaping how breast cancer screening services are delivered, particularly by overcoming traditional barriers related to location, accessibility, and socioeconomic status. Unlike fixed mammography units, portable systems offer the unique advantage of mobility, allowing healthcare providers to bring essential diagnostic services directly to patients who might otherwise face difficulties accessing care.

Segment Breakdown

By Product Type:

  • Analog Mammography Systems
  • Digital Mammography Systems

By Modality:

  • Portable Mammography Systems
  • Non-Portable Mammography Systems

By End User:

  • Impatient Settings
  • Ambulatory Surgical Centers

By Region:

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America holds the largest share of the global mammography systems market, a position that reflects several key factors driving the region's dominance. One of the primary reasons behind this leadership is the high level of patient awareness regarding breast cancer screening and early detection. This awareness translates into widespread demand for mammography services, encouraging healthcare providers to invest in the latest diagnostic technologies.
  • The mammography systems market in North America is also defined by considerable capital investment in state-of-the-art diagnostic equipment. Healthcare providers allocate significant resources to procure advanced mammography systems that offer enhanced imaging capabilities, faster processing, and improved patient comfort. These investments are necessary to meet the demands of a large screening population and to keep pace with technological advancements that continually refine diagnostic precision.

Leading Market Participants

  • Allengers Medical Systems Limited
  • Fujifilm Holding Corporation
  • General Electric Company
  • Hologic Incorporated
  • Konica Milota Incorporated
  • Koninklijke Philips N.V. (Philips Healthcare)
  • Metaltronica SPA
  • Planmeca OY
  • Siemens Aktiengesellschaft
  • Toshiba Corporation
  • Other Prominent Players

Table of Content

Chapter 1. Research Framework

  • 1.1 Research Objective
  • 1.2 Product Overview
  • 1.3 Market Segmentation

Chapter 2. Research Methodology

  • 2.1 Qualitative Research
    • 2.1.1 Primary & Secondary Sources
  • 2.2 Quantitative Research
    • 2.2.1 Primary & Secondary Sources
  • 2.3 Breakdown of Primary Research Respondents, By Region
  • 2.4 Assumption for the Study
  • 2.5 Market Size Estimation
  • 2.6. Data Triangulation

Chapter 3. Executive Summary: Global Mammography Systems Market

Chapter 4. Global Mammography Systems Market Overview

  • 4.1. Industry Value Chain Analysis
    • 4.1.1. Material Provider
    • 4.1.2. Manufacturers
    • 4.1.3. Distributor
    • 4.1.4. End user
  • 4.2. Industry Outlook
    • 4.2.1. Overview of Mammography Systems Market
    • 4.2.2. Demographic analysis under Mammography
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of Substitutes
    • 4.3.4. Threat of New Entrants
    • 4.3.5. Degree of Competition
  • 4.4. Market Dynamics and Trends
    • 4.4.1. Growth Drivers
    • 4.4.2. Restraints
    • 4.4.3. Challenges
    • 4.4.4. Key Trends
  • 4.5. Covid-19 Impact Assessment on Market Growth Trend
  • 4.6. Market Growth and Outlook
    • 4.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2020 - 2033
    • 4.6.3. Price Trend Analysis
  • 4.7. Competition Dashboard
    • 4.7.1. Market Concentration Rate
    • 4.7.2. Company Market Share Analysis (Value %), 2024
    • 4.7.3. Competitor Mapping
    • 4.7.4. Promotional Marketing Strategies and USPs

Chapter 5. Global Mammography Systems Market Analysis, By Product Type

  • 5.1. Key Insights
  • 5.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 5.2.1. Analog Mammography Systems
    • 5.2.2. Digital Mammography Systems

Chapter 6. Global Mammography Systems Market Analysis, By Modality

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 6.2.1. Portable Mammography Systems
    • 6.2.2. Non-Portable Mammography Systems

Chapter 7. Global Mammography Systems Market Analysis, By End User

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 7.2.1. Impatient Settings
    • 7.2.2. Ambulatory Surgical Centers

Chapter 8. Global Mammography Systems Market Analysis, By Region

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 8.2.1. North America
      • 8.2.1.1. The U.S.
      • 8.2.1.2. Canada
      • 8.2.1.3. Mexico
    • 8.2.2. Europe
      • 8.2.2.1. Western Europe
        • 8.2.2.1.1. The UK
        • 8.2.2.1.2. Germany
        • 8.2.2.1.3. France
        • 8.2.2.1.4. Italy
        • 8.2.2.1.5. Spain
        • 8.2.2.1.6. Rest of Western Europe
      • 8.2.2.2. Eastern Europe
        • 8.2.2.2.1. Poland
        • 8.2.2.2.2. Russia
        • 8.2.2.2.3. Rest of Eastern Europe
    • 8.2.3. Asia Pacific
      • 8.2.3.1. China
      • 8.2.3.2. India
      • 8.2.3.3. Japan
      • 8.2.3.4. South Korea
      • 8.2.3.5. Australia & New Zealand
      • 8.2.3.6. ASEAN
      • 8.2.3.7. Rest of Asia Pacific
    • 8.2.4. Middle East & Africa
      • 8.2.4.1. UAE
      • 8.2.4.2. Saudi Arabia
      • 8.2.4.3. South Africa
      • 8.2.4.4. Rest of MEA
    • 8.2.5. South America
      • 8.2.5.1. Argentina
      • 8.2.5.2. Brazil
      • 8.2.5.3. Rest of South America

Chapter 9. North America Mammography Systems Market Analysis

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 9.2.1. By Product Type
    • 9.2.2. By Modality
    • 9.2.3. By End User
    • 9.2.4. By Country

Chapter 10. Europe Mammography Systems Market Analysis

  • 10.1. Key Insights
  • 10.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 10.2.1. By Product Type
    • 10.2.2. By Modality
    • 10.2.3. By End User
    • 10.2.4. By Country

Chapter 11. Asia Pacific Mammography Systems Market Analysis

  • 11.1. Key Insights
  • 11.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 11.2.1. By Product Type
    • 11.2.2. By Modality
    • 11.2.3. By End User
    • 11.2.4. By Country

Chapter 12. Middle East and Africa Mammography Systems Market Analysis

  • 12.1. Key Insights
  • 12.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 12.2.1. By Product Type
    • 12.2.2. By Modality
    • 12.2.3. By End User
    • 12.2.4. By Country

Chapter 13. South America Mammography Systems Market Analysis

  • 13.1. Key Insights
  • 13.2. Market Size and Forecast, 2020 - 2033 (US$ Mn)
    • 13.2.1. By Product Type
    • 13.2.2. By Modality
    • 13.2.3. By End User
    • 13.2.4. By Country

Chapter 14. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 14.1. Allengers Medical Systems Limited
  • 14.2. Fujifilm Holding Corporation
  • 14.3. General Electric Company
  • 14.4. Hologic Incorporated
  • 14.5. Konica Milota Incorporated
  • 14.6. Koninklijke Philips N.V. (Philips Healthcare)
  • 14.7. Metaltronica SPA
  • 14.8. Planmeca OY
  • 14.9. Siemens Aktiengesellschaft
  • 14.10. Toshiba Corporation
  • 14.11. Other Prominent Players